|Podcasts|June 21, 2019
Episode 34: The Future of the Life Sciences Executive
Author(s)Lisa Henderson, Christen Harm
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
Advertisement
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
3
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5